U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Vaccines, Blood & Biologics
  3. International Activities
  4. Foreign Regulatory Seminar (Web-Based) - Office of Blood Research and Review
  1. International Activities

Foreign Regulatory Seminar (Web-Based) - Office of Blood Research and Review

FDA Regulation of Blood and Blood Components in the United States

Overview of the Office of Blood Research and Review, and its regulatory review of blood and blood products, including discussion of in vitro diagnostic devices, Class II and III devices, blood collection, and source plasma.

Medical Device Review at CBER

Detailed discussion on the regulatory process for medical devices at CBER, a review of definitions, explanation of why the Center for Biologics reviews devices, and reporting requirements.

Blood Screening IVDs

Discussion on blood screening in vitro diagnostics, including safety, required screening/testing, and a brief discussion on the Investigational New Drug application (IND)/Biologics License Application (BLA) process.

Return to Foreign Regulatory Seminar (Web-Based)

 

Back to Top